Clinical Trial Update: A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques [Phase 1]

View source ↗

Summary

A Phase 1 study sponsored by GlaxoSmithKline to assess inflammation in rheumatoid arthritis using molecular imaging techniques has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: TERMINATED